At the International AIDS Conference, the Global Fund to Fight AIDS, Tuberculosis and Malaria joined efforts to accelerate the end of the HIV epidemic, linking civil society, scientific experts and policymakers from all over the world on the conferen...
Global Fund strikes agreements with suppliers of HIV medication that will save US$324 million by the end of 2021 and secure the supply of HIV drugs for 4 million people
Peter Sands, Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, today named Philippe François as Head of Sourcing & Supply Chain, bringing a recognized track record of innovation in supplying healthcare products and servic...
Peter Sands, Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, today announced the appointments of three new leaders joining the senior management team to accelerate the Global Fund’s work toward ending epidemics..
The Global Fund today joins leaders meeting at the Malaria Summit London 2018 in a call to reduce malaria by one half across the Commonwealth in the next five years. Such collective actions aims to prevent 350 million cases of malaria and save 650,00...
Today the United Kingdom's International Development Secretary Penny Mordaunt announced a £100 million fund to fight malaria to be matched by the private sector, which will be used to support priority countries with mosquito nets, indoor sprays and t...
The Global Fund today suspended its partnership with Heineken based on recent reports of the company’s use of female beer promoters in ways that expose them to sexual exploitation and health risks.
The Global Fund applauds the U.S. Congress for approving $1.35 billion in funding for the Global Fund for the 2018 U.S. fiscal year. This tremendous support from the United States is essential as the Global Fund accelerates progress in the fight agai...
The Global Fund uses cookies for anonymized statistics on website use and content performance to help us improve and adapt the website.
To consent to the use of cookies, please click “Accept”. To learn more about your rights and options, please read our Privacy Statement.